MEET OUR TEAM

We trust our experts

Thoas Fioretos, MD, PhD

Chairman of the Board, Founder

Professor and senior consultant at the Division of Clinical Genetics, Lund university. Thoas has published more than 150 scientific articles and he is a recipient of the Wallenberg Clinical Scholar Award and an elected member of the Royal Swedish Academy of Sciences. Founder of the two public companies Qlucore AB and Cantargia AB.

Lars Bruzelius PhD

Board member

Associate Professor in Business Administration and a management consultant. Previous Vice President and Administrative Director at Gambro AB and member of the board of Cantargia, Follicum, and many other companies.

Anki Malmborg Hager, MSC, PhD

CEO, Board member

Previous CEO of SenzaGen AB, PainDrainer AB, Cantargia AB, XImmune AB, and Diaprost AB.  Previous Investment Director at LU Bioscience AB and the VP for Business Development at Alligator Bioscience AB. Advisor and board member of several start-up companies.

Kjell Sjöström, MSc

Board member, founder

A life science entrepreneur, founder of Innovagen AB 1995, deeply involved in bringing several antibodies into clinical development. One of the founders of Cantargia AB, Pharma15 Corp.

Marcus Järås, PhD

Board member, Founder

Associate Professor at the Division of Clinical Genetics at Lund University, Head of Research Education at the Department for Laboratory Medicine, Lund University. One of the founders of Cantargia AB and an inventor of several patents related to antibody therapeutics for cancer treatment.

Carl Sandén, PhD

Chief Scientific Officer, Founder

Senior research scientist at the Division of Clinical Genetics at Lund University with a PhD in experimental hemtaology and extensive experience in experimental and translational cancer research. He specializes in target identification and validation for antibody therapy in cancer.

Niklas Landberg, MD, PhD

Medical Advisor, Founder

A physician-scientist working at the Department of Hematology at Skåne University Hospital and Clinical Genetics at Lund University. He conducted his postdoctoral research at Stanford University. Part of Swedish National steering committee for Acute Myeloid Leukemia.